Polypill for cardiovascular disease prevention provokes debate

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1507, 2005-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A placebo-controlled clinical trial of a four-in-one polypill for cardiovascular disease is now underway in the UK

Inpharma, Vol. 1, Iss. 1663, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Pharmaceutical thrombosis prevention in cardiovascular disease

By Eriksson Mats Christensen Kjeld Lindahl Tomas L Larsson Anders

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 4, 2002-04 ,pp. : 553-563

Informa Healthcare

Access to resources Recommend Favorite

Lipid Management for the Prevention of Cardiovascular Disease

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 852-860

Bentham Science Publishers

Access to resources Recommend Favorite

Garlic for Cardiovascular Disease: Prevention or Treatment?

Current Pharmaceutical Design, Vol. 23, Iss. 7, 2017-04 ,pp. : 1028-1041

Bentham Science Publishers

Access to resources Recommend Favorite

Polypill may be new miracle cocktail for cardiovascular disorders

Inpharma, Vol. 1, Iss. 1394, 2003-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite